CDX2 and ovarian mucinous adenocarcinoma: In gynecological cancer, immunohistochemical detection of CDX2 can be a useful marker to distinguish metastatic colorectal carcinoma involving the ovary from primary ovarian mucinous adenocarcinoma 17, 18.